0299-6220-10 : NDC 2026 Code

0299-6220-10 : Nemolizumab-ilto ( Nemluvio )

Additionally :

You can get information about “0299-6220-10” NDC code in 0299-6220-10 in HTML format

HTML | 0299-6220-10 in TXT (Plain Text) format

TXT | 0299-6220-10 in PDF (Portable Document Format)

PDF | 0299-6220-10 in XML format

XML formats.

NDC Code : 0299-6220-10 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "0299-6220-10",
    "PackageDescription": "1 SYRINGE, GLASS in 1 CARTON (0299-6220-10)  / 30 mg in 1 SYRINGE, GLASS",
    "NDC11Code": "00299-6220-10",
    "ProductNDC": "0299-6220",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Nemluvio",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Nemolizumab-ilto",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20240813",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761390",
    "LabelerName": "Galderma Laboratories, L.P.",
    "SubstanceName": "NEMOLIZUMAB",
    "StrengthNumber": "30",
    "StrengthUnit": "mg/100mg",
    "Pharm_Classes": "Interleukin-31 Receptor alpha Antagonist [EPC], Interleukin-31 Receptor alpha Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-17",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20240813",
    "EndMarketingDatePackage": null,
    "SamplePackage": "Y"
  }
}